Cellares and Sonoma Partner to Automate Cell Therapy Manufacturing

Cellares and Sonoma Biotherapeutics Collaborate to Automate Manufacturing of SBT-77-7101 Engineered Treg Cell Therapy on the Cell Shuttle® Platform

SOUTH SAN FRANCISCO, Calif. & SEATTLE--(BUSINESS WIRE)--Jul 13, 2026-

Cellares, Sonoma partner to automate cell therapy manufacturing

SBT-77-7101 is described as an autologous CAR-Treg cell therapy currently in Phase I clinical development to treat patients with poly-refractory rheumatoid arthritis (RA). These patients with RA have The post Cellares and Sonoma partner to automate cell therapy manufacturing appeared first on Pharmaceutical Business review.

Cellares and Sonoma partner to automate cell therapy manufacturing

Cellares and Sonoma Biotherapeutics have partnered to automate the manufacturing of the latter’s SBT-77-7101 programme using the Cellares Cell Shuttle platform.The post Cellares and Sonoma partner to automate cell therapy manufacturing appeared first on Hospital Management.

Cellares and Sonoma Biotherapeutics Collaborate to ...